Prosecution Insights
Prosecution Insights
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EIX, EMILY FAY | 1 | 45.5% | +78.3% |
| SPANGLER, JOSEPH RANKIN | 1 | 40.3% | +68.8% |
| CHASE, CAROL ANN | 1 | 42.6% | +84.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18710640 | UNDERGLYCOSYLATED KALLIKREIN I, AND POLYETHYLENE GLYCOL MODIFIER THEREOF AND PHARMACEUTICAL USE THEREOF | SPANGLER, JOSEPH RANKIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18725848 | RECOMBINANT TYPE I ALLERGEN OF ARTEMISIA ANNUA POLLEN, AND PREPARATION METHOD AND USE THEREOF | EIX, EMILY FAY | — |
| 18710640 | UNDERGLYCOSYLATED KALLIKREIN I, AND POLYETHYLENE GLYCOL MODIFIER THEREOF AND PHARMACEUTICAL USE THEREOF | SPANGLER, JOSEPH RANKIN | — |
| 18704066 | ANTI-CD26 ANTIBODIES AND USE THEREOF | CHASE, CAROL ANN | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18725848 | RECOMBINANT TYPE I ALLERGEN OF ARTEMISIA ANNUA POLLEN, AND PREPARATION METHOD AND USE THEREOF | EIX, EMILY FAY | — | §103 | Non-Final OA | — | Pending | Jul 01, 2024 |
| 18710640 | UNDERGLYCOSYLATED KALLIKREIN I, AND POLYETHYLENE GLYCOL MODIFIER THEREOF AND PHARMACEUTICAL USE THEREOF | SPANGLER, JOSEPH RANKIN | 1656 | §101§102§103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18704066 | ANTI-CD26 ANTIBODIES AND USE THEREOF | CHASE, CAROL ANN | — | §112DP | Non-Final OA | — | Pending | Apr 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial